Summary of structural dynamics of WT and mutant RhoGAPs-RhoA complexes. by Zen Kouchi (14898435)

List of candidate genes around of significant SNPs identified by heterozygous (dis)advantage GWAS model. by Miriam Suzane Vidotti (6812327)

Non statistically significant variables associated with endometriosis (bivariate analysis). by Giuseppe Ricci (311646)

Results of multivariate analyses. by Rodney Plat (16052831)

“…</p><p>Results</p><p>We found a significant but geographically heterogeneous nationwide reduction in ACS admissions during lockdown (IRR 0·70 [0·64–0·76]). …”

Chromosomes with significant effects for qualitative traits. by Bernadette Yougbaré (11237724)

Chromosomes with significant effects for trypanosomosis status. by Bernadette Yougbaré (11237724)

Vibriocidal activities were significantly decreased by depletion of IgM in serum. by Jae Seung Yang (701319)

Transcriptional and translational markers of syncytialization and biochemical differentiation are significantly decreased by rotenone. by O’Llenecia S. Walker (8486163)

DICER protein expression is significantly decreased in the absence of MOV10 and FMRP. by Monica C. Lannom (11772729)

Top 15 significant exposures applied, and the directions of their associations with RRV. by Wei Qian (56612)

Brain regions with significantly decreased activations for the Raven task are shown in blue. by Morteza Fattahi (15892028)

Glucose disposal rate (GDR) is significantly decreased in P HFHS dams. by Akansha Mishra (2632600)

Pleiotropic analyses. by Brenton R. Swenson (6894086)

Health system factors associated with unfavorable treatment outcomes in people with drug-susceptible TB (Gap 4). by Tulip A. Jhaveri (18625800)

“…Only statistically significant findings are presented. Some studies in the review with adjusted analyses reported nonsignificant findings for health system dissatisfaction [<a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1004409#pmed.1004409.ref093" target="_blank">93</a>], proximity to the nearest clinic [<a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1004409#pmed.1004409.ref041" target="_blank">41</a>,<a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1004409#pmed.1004409.ref093" target="_blank">93</a>,<a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1004409#pmed.1004409.ref108" target="_blank">108</a>], treatment costs [<a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1004409#pmed.1004409.ref091" target="_blank">91</a>,<a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1004409#pmed.1004409.ref093" target="_blank">93</a>], number of providers visited [<a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1004409#pmed.1004409.ref091" target="_blank">91</a>], type of DOT provider [<a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1004409#pmed.1004409.ref041" target="_blank">41</a>,<a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1004409#pmed.1004409.ref084" target="_blank">84</a>], type of case finding approach [<a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1004409#pmed.1004409.ref127" target="_blank">127</a>], type of adherence monitoring approach [<a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1004409#pmed.1004409.ref075" target="_blank">75</a>,<a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1004409#pmed.1004409.ref084" target="_blank">84</a>,<a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1004409#pmed.1004409.ref105" target="_blank">105</a>,<a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1004409#pmed.1004409.ref109" target="_blank">109</a>], and incorrect and/or inadequate information given by providers [<a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1004409#pmed.1004409.ref073" target="_blank">73</a>,<a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1004409#pmed.1004409.ref093" target="_blank">93</a>,<a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1004409#pmed.1004409.ref123" target="_blank">123</a>]. …”

Significant SNPs identified through GWAS analyses by Chenyong Miao (4742712)

Cohorts used for analyses. by Mikhail Vysotskiy (16015900)

Number of patients with a significant increase or significant decrease between the baseline measurement (SCr-BL) and the creatinine measurement at emergency department presentation (SCr-ED). by M. S. A. Niemantsverdriet (11886431)

GO analysis of stage-salient genes in the order of decreasing significance (i.e, increasing p–value). by Sangeetha Muthamilselvan (8966006)

Significantly decreased adhesion to host cells by the Δ<i>tad123</i> mutant (A) and time-dependent recovery (B). by Tra-My Duong-Nu (7300970)

The summary results of 25 significant lung cancer-associated proteins. by Zhangyan Lyu (4070221)

Subjects: